To the Editor A recent study that aimed to assess the prognostic value of routinely available cardiovascular biomarkers when added to established risk factors found that incorporating these biomarkers resulted in only a modest improvement in risk prediction metrics for atherosclerotic cardiovascular disease. However, the improvement was more notable for predicting heart failure and mortality. Despite these interesting results, several issues warrant further attention.
